Pediatric Hematopoietic Stem Cell Transplant Medication Adherence Facilitators and Strategies: A Qualitative Study

Marie L Chardon1, Kimberly L Klages1, Naomi E Joffe1,2,3

  • 1Division of Behavioral Medicine & Clinical Psychology, Cincinnati Children's Hospital Medical Center, USA.

Insights

Caregivers of children undergoing hematopoietic stem cell transplant (HCT) develop many strategies for medication adherence. However, caregiver burden remains high, indicating a need for tailored multidisciplinary support post-HCT.

Area of Science:

  • Pediatric Hematology/Oncology
  • Transplantation Medicine
  • Adolescent and Young Adult Medicine

Background:

  • Medication adherence is critical for pediatric survival post-hematopoietic stem cell transplant (HCT).
  • Suboptimal adherence is a common challenge in this vulnerable population.
  • Understanding facilitators and strategies is essential for developing effective interventions.

Purpose of the Study:

  • To examine caregiver-perceived medication adherence facilitators and strategies after pediatric HCT.
  • To identify factors that promote or hinder medication management in children post-transplant.
  • To inform the development of targeted adherence interventions.

Main Methods:

  • Qualitative study employing semi-structured interviews with 29 caregivers of children (≤12 years) within 2 years of HCT.
  • Demographic questionnaires collected alongside interviews.
  • Thematic analysis guided by grounded theory to identify key themes.

Main Results:

  • Four main categories of facilitators and strategies emerged: family, medication, caregiver, and multidisciplinary treatment team.
  • Caregivers demonstrated resourcefulness, independently developing numerous adherence strategies.
  • Identified facilitators and strategies varied among caregivers and evolved over time.

Conclusions:

  • Caregivers are resourceful but experience significant burden managing medications post-HCT.
  • Individualized, multicomponent support from the multidisciplinary team is crucial, especially after hospital discharge.
  • Further research should focus on developing and evaluating interventions to alleviate caregiver burden and improve adherence.
Abstract

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
75
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
479
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
90
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.2K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K